Iptacopan significantly slowed kidney function decline over 24 months compared with placebo in adults with IgA nephropathy. The complement inhibitor was granted accelerated approved in 2024; continued ...
Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease. But the ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Michael Sullivan Michael Sullivan is a writer covering kitchen equipment and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results